FDA Looking At Investigator Histories To Identify Problem Sponsors
Executive Summary
FDA plans to "link" drug company sponsors to the quality of data submitted by clinical investigators, Office of Compliance Director Stephanie Gray told the University of Texas at Austin's International Industrial Pharmacy Conference Feb. 25.